The results showed a desirable reduction in all types of lymphocytes, including NK cells, B lymphocytes, CD8 + T lymphocytes, and CD4 + T lymphocytes in COVID-19 patients, especially those with severe symptoms. This evidence concerns the gene CD8A and COVID-19.